Gabriela Québatte

Dr. Gabriela Québatte

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
HKHelene Kettiger
Helene Kettiger
GQGabriela Québatte
Gabriela Québatte
BPBarbara Perrone
Barbara Perrone
JHJoerg Huwyler
Joerg Huwyler

1 March 2014 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
GQGabriela Québatte
Gabriela Québatte
EKEric Kitas
Eric Kitas
JSJoachim Seelig
Joachim Seelig

9 September 2013 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
GQGabriela Québatte
Gabriela Québatte
EKEric Kitas
Eric Kitas
JSJoachim Seelig
Joachim Seelig

15 January 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MFMaryam Farzan
Maryam Farzan
RRRoger Roth
Roger Roth
GQGabriela Québatte
Gabriela Québatte
JSJoachim Schoelkopf
Joachim Schoelkopf
JHJoerg Huwyler
Joerg Huwyler
MPMaxim Puchkov
Maxim Puchkov
Accurate analysis of intraparticle distribution of substances within porous drug carriers is important to optimize loading and subsequent processing. Mercury intrusion porosimetry, a common technique used for characterization of porous materials, assumes cylindrical pore geometry, which may lead to misinterpretation. Therefore, imaging techniques such as focused ion beam scanning electron microscopy (FIB-SEM) help to better interpret these results. The purpose of this study was to investigate the differences between mercury intrusion and scanning electron microscopy and to identify the limitations of each method. Porous microparticles, functionalized calcium carbonate, were loaded with bovine serum albumin and dipalmitoylphosphatidylcholine (DPPC) by solvent evaporation and results of the pore size distribution obtained by both methods were compared. The internal structure of the novel pharmaceutical excipient, functionalized calcium carbonate, was revealed for the first time. Our results demonstrated that image analysis provides a closer representation of the material distribution since it was possible to discriminate between blocked and filled pores. The physical nature of the loaded substances is critical for the deposition within the pores of functionalized calcium carbonate. We conclude, that a combination of mercury intrusion porosimetry and focused ion beam scanning electron microscopy allows for a reliable analysis of sub-micron porous structures of particulate drug carriers.

1 January 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
LWLeonie Wagner-Hattler
Leonie Wagner-Hattler
GQGabriela Québatte
Gabriela Québatte
JKJennifer Keiser
Jennifer Keiser
JSJoachim Schoelkopf
Joachim Schoelkopf
CSChristian Schlepütz
Christian Schlepütz
MPMaxim Puchkov
Maxim Puchkov

1 January 2016 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
PGPhilip Grossen
Philip Grossen
GQGabriela Québatte
Gabriela Québatte
DWDominik Witzigmann
Dominik Witzigmann
CPCristina Prescianotto-Baschong
Cristina Prescianotto-Baschong
LDLe-Ha Dieu
Le-Ha Dieu
JHJoerg Huwyler
Joerg Huwyler
Nanoparticles are increasingly used to implement drug targeting strategies. In the present study, solid-sphere nanoparticles (SNPs) made of poly(ethylene glycol)-b-poly(ε-caprolactone) (PEG-b-PCL) were covalently linked to a monoclonal antibody (83-14 mAb) targeted against the human insulin receptor that is highly expressed on human brain microvascular endothelial cells. Resulting targeted SNPs were characterized using transmission electron microscopy (TEM), cryo-TEM, dynamic light scattering, and fluorescence correlation spectroscopy. The critical aggregation concentration was determined using a fluorescence approach. Interaction with a well-characterized humanin vitromodel of the blood-brain barrier (hCMEC/D3) was analysed using an array of methods (flow cytometry, confocal laser scanning microscopy, and TEM). The toxicity on hCMEC/D3 cells and in addition on the human liver cell line HepG2 was assessed using the MTT assay. SNPs with a diameter of 80 nm and a homogeneous size distribution were obtained. Successful conjugation of 83-14 mAb using a heterobifunctional linker resulted in 5-6 molecules of fluorescently labeled 83-14 mAb per SNP. Functionalized SNPs were taken up by hCMEC/D3 cells efficiently without showing a significant toxic effect on cells of the blood-brain barrier and HepG2 cells. These results indicate that functionalized PEG-b-PCL SNPs are a promising candidate to deliver drugs to the CNS.